| 000 | 01599 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518045518.0 | ||
| 264 | 0 | _c20190709 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1756-1833 | ||
| 024 | 7 |
_a10.1136/bmj.l2222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYin, Shang-He-Lin | |
| 245 | 0 | 0 |
_aDuration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent: systematic review and network meta-analysis. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _c06 2019 |
||
| 300 |
_al2222 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xdrug therapy |
| 650 | 0 | 4 |
_aClopidogrel _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xstandards |
| 650 | 0 | 4 |
_aHemorrhage _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xmethods |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aThrombosis _xepidemiology |
| 700 | 1 | _aXu, Peng | |
| 700 | 1 | _aWang, Bian | |
| 700 | 1 | _aLu, Yao | |
| 700 | 1 | _aWu, Qiao-Yu | |
| 700 | 1 | _aZhou, Meng-Li | |
| 700 | 1 | _aWu, Jun-Ru | |
| 700 | 1 | _aCai, Jing-Jing | |
| 700 | 1 | _aSun, Xin | |
| 700 | 1 | _aYuan, Hong | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 365 _gp. l2222 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.l2222 _zAvailable from publisher's website |
| 999 |
_c29850151 _d29850151 |
||